Earnings Feed
Start Free
Home/Filings/4/0000914190-16-000614
4//SEC Filing

Arno Therapeutics, Inc 4

Accession 0000914190-16-000614

CIK 0001195116operating
View on SEC.govCompany Profile

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 4:22 PM ET

Size

17.4 KB

Accession

0000914190-16-000614

Insider Transaction Report

Form 4
Period: 2016-04-07
Arno Therapeutics, IncARNI
Proniuk Stefan
VP of Product Development
Transactions
  • Award

    Stock Option (right to buy)

    2016-04-07+554,685→ 554,685 total
    Exercise: $0.37Exp: 2026-04-07→ Common Stock (554,685 underlying)
Holdings

  • Common Stock

    10,047

  • Stock Option (right to buy)

    Exercise: $2.40Exp: 2023-11-04→ Common Stock (45,701 underlying)
    45,701

  • Stock Option (right to buy)

    Exercise: $2.40Exp: 2021-06-20→ Common Stock (7,191 underlying)
    7,191

  • Stock Option (right to buy)

    Exercise: $2.40Exp: 2021-09-19→ Common Stock (10,000 underlying)
    10,000

  • Stock Option (right to buy)

    Exercise: $2.40Exp: 2023-01-14→ Common Stock (2,291 underlying)
    2,291

  • Stock Option (right to buy)

    Exercise: $2.90Exp: 2024-01-24→ Common Stock (171,877 underlying)
    171,877

  • 2012 Series A Warrants (right to buy)

    Exercise: $1.36From: 2012-11-26Exp: 2017-11-26→ Common Stock (24,508 underlying)
    24,508

  • Stock Option (right to buy)

    Exercise: $2.40Exp: 2021-06-20→ Common Stock (17,187 underlying)
    17,187

  • Stock Option (right to buy)

    Exercise: $2.40Exp: 2023-01-14→ Common Stock (6,875 underlying)
    6,875
Footnotes (5)
  • [F1]Currently exercisable.
  • [F2]Vests in equal 36-monthly installments commencing 12/4/13.
  • [F3]Vests 25% on first anniversary date and thereafter will vest in 24 equal monthly installments.
  • [F4]Vests one-third on the first anniversary of grant and thereafter in 24 equal monthly installments.
  • [F5]As a result of the Issuer's 1/12/16 private placement of common stock at $0.35/share, the exercise price and number of shares subject to the 2012 Series A Warrants were automatically adjusted to the exercise price and shares reflected, pursuant to anti-dilution adjustment provisions.

Documents

1 file

Issuer

Arno Therapeutics, Inc

CIK 0001195116

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001195116

Filing Metadata

Form type
4
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:22 PM ET
Size
17.4 KB
View on SEC.gov